Nomura Asset Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-130
Closed -$15.3K – 1555
2026
Q1
$15.3K Hold
130
– – ﹤0.01% 1485
2025
Q4
$21.3K Hold
130
– – ﹤0.01% 1405
2025
Q3
$17.4K Hold
130
– – ﹤0.01% 1461
2025
Q2
$16.2K Hold
130
– – ﹤0.01% 1475
2025
Q1
$16.5K Buy
+130
New +$20K ﹤0.01% 1496
2024
Q3
– Sell
-13,050
Closed -$1.65M – 1510
2024
Q2
$1.65M Hold
13,050
– – 0.01% 737
2024
Q1
$2.4M Hold
13,050
– – 0.01% 692
2023
Q4
$2.35M Hold
13,050
– – 0.01% 697
2023
Q3
$2.08M Buy
13,050
+1,110
+9% +$181K 0.01% 704
2023
Q2
$1.69M Hold
11,940
– – 0.01% 733
2023
Q1
$2.01M Hold
11,940
– – 0.01% 699
2022
Q4
$2.02M Buy
+11,940
New +$2.17M 0.01% 687

Other funds holding RGEN

Nomura Asset Management's RGEN Position: Q2 2026 in Review

Nomura Asset Management sold out of Repligen (RGEN) in Q2 2026, closing a stake of 130 shares — an estimated $15.3K sold.

Nomura Asset Management first reported a position in RGEN in Q4 2022 and held it in 12 quarters. The position peaked at $2.4M in Q1 2024. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Nomura Asset Management reported no remaining Repligen position as of Q2 2026 after selling out during the quarter.
  • Nomura Asset Management sold 130 Repligen shares in Q2 2026, an estimated $15.3K.
  • Nomura Asset Management first reported a position in Repligen in Q4 2022 and held it in 12 quarters.
  • Nomura Asset Management's Repligen position peaked at $2.4M in Q1 2024.
  • 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.